About | Free Trial

Last Update

2015-10-06T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Rick Winningham?

Mr. Rick Winningham E.

Chairman and Chief Executive Officer

Theravance , Inc.

Direct Phone: (650) ***-****       

Theravance , Inc.

901 Gateway Blvd

S. San Francisco, California 94080

United States

Company Description

Theravance, Inc. (Theravance) is a biopharmaceutical company with a pipeline of internally discovered product candidates. The Company is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic ... more

Find other employees at this company (410)

Background Information

Employment History

Chief Executive Officer and A Member of the Board of Directors
Theravance , Inc.

Chief Executive Officer
Theravance , Inc.

Chairman of Directors
California Healthcare Institute Inc

Lead Independent Director
Jazz Pharmaceuticals plc

President
Global Marketing

President
Bristol-Myers Squibb Company

Various Management Positions
Bristol-Myers Squibb Company

Affiliations

Board Member
California Healthcare Institute Inc

Chairman, Development Committee
California Healthcare Institute Inc

Board Member
Jazz Pharmaceuticals plc

Education

B.S.

Southern Illinois University

M.B.A.

Texas Christian University

B.S. degree

Southern Illinois University

Web References (138 Total References)


Theravance, Inc. and Theravance Biopharma, Inc. Announce Completion of Separation of Late-Stage Partnered Respiratory Assets From Biopharmaceutical Operations (NASDAQ:THRX)

thera.client.shareholder.com [cached]

"Now that we have completed the separation, each company will focus its efforts on building value by unlocking unique and promising opportunities," said Rick E Winningham, Chief Executive Officer of both

...
Rick Winningham
...
Rick E Winningham 650-808-4045 investor.relations@theravance.com


This is evidenced not only by ...

www.biospace.com [cached]

This is evidenced not only by today's sNDA milestone but also our ongoing Phase 3 registrational study of telavancin in Staphylococcus aureus bacteremia," said Rick E Winningham, Chairman and Chief Executive Officer of Theravance Biopharma.


Theravance Biopharma, Inc.: Committee Composition

investor.theravance.com [cached]

Rick E Winningham Chairman and Chief Executive Officer

Rick E Winningham has served as Chief Executive Officer and Chairman of the Board of Directors of Theravance Biopharma since its spin-off from Theravance, Inc. in June 2014. From October 2001 to August 2014, Mr. Winningham served as Chief Executive Officer of Theravance, Inc., where he also served as Chairman of the Board of Directors from April 2010 to October 2014. Prior to joining Theravance, Inc., he served as President, Bristol-Myers Squibb (BMS) Oncology/Immunology/Oncology Therapeutics Network (OTN) from 1997 to 2001, and also as President of Global Marketing from 2000 to 2001. In addition to operating responsibility for U.S. Oncology/Immunology/OTN, Mr. Winningham also had full responsibility for Global Marketing in the Cardiovascular, Infectious Disease, Immunology, Oncology/Metabolics and GU/GI/Neuroscience therapeutic areas. Over a fifteen-year period with BMS and its predecessor, Bristol-Myers, Mr. Winningham held various U.S. and global management positions. During his tenure with BMS, he was associated with the development and commercialization of several major pharmaceutical products, such as Taxol®, Paraplatin®, Zerit®, Videx®, Reyataz®, and Abilify®.
Mr. Winningham holds an M.B.A. from Texas Christian University and a B.S. from Southern Illinois University. He is the Chairman of the Board of Directors of California Healthcare Institute (CHI) and a member of the Board of Directors of Jazz Pharmaceuticals. Mr. Winningham is also a member of Biotechnology Industry Organization's Board of Directors and serves on the Health Section Governing Board Standing Committee on Reimbursement.
...
Rick E Winningham Chairman of the Board
...
Rick E Winningham Chairman and Chief Executive Officer
Rick E Winningham has served as Chief Executive Officer and Chairman of the Board of Directors of Theravance Biopharma since its spin-off from Theravance, Inc. in June 2014. From October 2001 to August 2014, Mr. Winningham served as Chief Executive Officer of Theravance, Inc., where he also served as Chairman of the Board of Directors from April 2010 to October 2014. Prior to joining Theravance, Inc., he served as President, Bristol-Myers Squibb (BMS) Oncology/Immunology/Oncology Therapeutics Network (OTN) from 1997 to 2001, and also as President of Global Marketing from 2000 to 2001. In addition to operating responsibility for U.S. Oncology/Immunology/OTN, Mr. Winningham also had full responsibility for Global Marketing in the Cardiovascular, Infectious Disease, Immunology, Oncology/Metabolics and GU/GI/Neuroscience therapeutic areas. Over a fifteen-year period with BMS and its predecessor, Bristol-Myers, Mr. Winningham held various U.S. and global management positions. During his tenure with BMS, he was associated with the development and commercialization of several major pharmaceutical products, such as Taxol®, Paraplatin®, Zerit®, Videx®, Reyataz®, and Abilify®.
Mr. Winningham holds an M.B.A. from Texas Christian University and a B.S. from Southern Illinois University. He is the Chairman of the Board of Directors of California Healthcare Institute (CHI) and a member of the Board of Directors of Jazz Pharmaceuticals. Mr. Winningham is also a member of Biotechnology Industry Organization's Board of Directors and serves on the Health Section Governing Board Standing Committee on Reimbursement.


Rick E Winningham, age 55, ...

www.sec.gov [cached]

Rick E Winningham, age 55, has served as a member of our board of directors since the Azur Merger and was a director of Jazz Pharmaceuticals, Inc. from 2010 until the Azur Merger. In May 2014, Mr. Winningham was appointed as Lead Independent Director of our board of directors. Mr. Winningham has served as Chief Executive Officer and Chairman of the Board of Directors of Theravance Biopharma, Inc., a biopharmaceutical company, since its spin-off from Theravance, Inc., a biopharmaceutical company, in June 2014. From October 2001 to August 2014, Mr. Winningham served as Chief Executive Officer of Theravance, Inc., where he also served as Chairman of the Board of Directors from April 2010 to October 2014. From 1997 to 2001, he served as President of Bristol-Myers Squibb Oncology/Immunology/Oncology Therapeutics Network and, from 2000 to 2001, as President of Global Marketing. He is Chairman of the board of directors of the California Healthcare Institute. Mr. Winningham is also a member of Biotechnology Industry Organization’s board of directors, serving on the health section governing board and board standing committee on reimbursement. Mr. Winningham holds a M.B.A. from Texas Christian University and a B.S. from Southern Illinois University. Mr. Winningham’s experience in senior management positions in the pharmaceutical industry provides significant industry knowledge and operational and management expertise to our board of directors.

...
Mr. Winningham currently serves as our Lead Independent Director.


Board of Directors - CHI

www.chi.org [cached]

Rick E. Winningham

...
Rick E. Winningham

Similar Profiles

Other People with this Name

Other people with the name Winningham

Brandon Winningham
Tegrit

Nicole Winningham
Gillam & Smith L.L.P

Dave Winningham
Redeemer Lutheran Church

Sam Winningham
DHS

Matthew Winningham
La Salle Prep

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory